Creative Planning’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-22,000
| Closed | -$259K | – | 2210 |
|
2020
Q3 | $259K | Sell |
22,000
-8,600
| -28% | -$101K | ﹤0.01% | 1497 |
|
2020
Q2 | $452K | Hold |
30,600
| – | – | ﹤0.01% | 1074 |
|
2020
Q1 | $413K | Hold |
30,600
| – | – | ﹤0.01% | 1032 |
|
2019
Q4 | $740K | Buy |
30,600
+860
| +3% | +$20.8K | ﹤0.01% | 923 |
|
2019
Q3 | $572K | Sell |
29,740
-600
| -2% | -$11.5K | ﹤0.01% | 988 |
|
2019
Q2 | $897K | Buy |
30,340
+3,785
| +14% | +$112K | ﹤0.01% | 797 |
|
2019
Q1 | $1.26M | Buy |
+26,555
| New | +$1.26M | ﹤0.01% | 630 |
|
2018
Q3 | – | Sell |
-4,200
| Closed | -$284K | – | 2022 |
|
2018
Q2 | $284K | Hold |
4,200
| – | – | ﹤0.01% | 1397 |
|
2018
Q1 | $228K | Buy |
4,200
+600
| +17% | +$32.6K | ﹤0.01% | 1508 |
|
2017
Q4 | $215K | Sell |
3,600
-600
| -14% | -$35.8K | ﹤0.01% | 1550 |
|
2017
Q3 | $204K | Buy |
4,200
+600
| +17% | +$29.1K | ﹤0.01% | 1581 |
|
2017
Q2 | $189K | Sell |
3,600
-1
| -0% | -$53 | ﹤0.01% | 1538 |
|
2017
Q1 | $163K | Hold |
3,601
| – | – | ﹤0.01% | 1611 |
|
2016
Q4 | $136K | Buy |
3,601
+501
| +16% | +$18.9K | ﹤0.01% | 1643 |
|
2016
Q3 | $117K | Sell |
3,100
-500
| -14% | -$18.9K | ﹤0.01% | 1735 |
|
2016
Q2 | $63K | Buy |
3,600
+2,200
| +157% | +$38.5K | ﹤0.01% | 1971 |
|
2016
Q1 | $17K | Buy |
1,400
+400
| +40% | +$4.86K | ﹤0.01% | 2864 |
|
2015
Q4 | $24K | Sell |
1,000
-300
| -23% | -$7.2K | ﹤0.01% | 2686 |
|
2015
Q3 | $23K | Buy |
+1,300
| New | +$23K | ﹤0.01% | 2616 |
|
2015
Q2 | – | Sell |
-2,000
| Closed | -$63K | – | 3136 |
|
2015
Q1 | $63K | Buy |
+2,000
| New | +$63K | ﹤0.01% | 1845 |
|